Ethicon empathises with women who have experienced complications following pelvic mesh procedures.
It’s important to note pelvic mesh has helped improve the quality of life for millions of women worldwide with stress urinary incontinence and pelvic organ prolapse. Scientists from around the world who have conducted and reviewed independent research on pelvic mesh agree it is an important treatment option for women, with the vast majority experiencing an improvement in their day to day lives.
Ethicon is reviewing today’s Federal Court decision and will consider its options to appeal.
Ethicon believes that the company acted ethically and responsibly in the research, development and supply of these products.
Ethicon supports continued access for Australian women to safe and effective treatments and encourages informed treatment decisions made in consultation with doctors on the benefits and risks of surgical procedures that utilise pelvic mesh devices.
